As DSM’s Chief Innovation Officer, Trish Malarkey shapes DSM’s long-term innovation strategy, accelerating and supporting innovation throughout the company and creating new businesses to deliver DSM’s Purpose-Led, Performance-Driven strategy. Trish has 30 years of experience in agricultural innovation. With extensive experience in senior R&D Leadership positions in multinational companies like AgrEvo and Syngenta, she has a breadth of technical knowledge across biology, chemistry, and biotechnology. Trish has successfully executed the delivery of innovation for commercial success, translated business strategies into technology pipelines and most recently as Head of Research & Development at Syngenta, led around 5000 scientific professionals in over 90 countries, recreating the R&D strategy, innovation pipeline, and organizational capabilities. Trish has also acted as a Scientific Advisor for a number of private equity companies and as a NonExecutive Director for Novozymes. Trish joined DSM in 2019. She is a British and American national, based in Geleen, The Netherlands.
Metabolomics & the Microbiome Meeting 2022Registration website for Metabolomics & the Microbiome Meeting 2022
Netherlands Metabolomics Centrefemke.email@example.com
Netherlands Metabolomics Centrefemke.firstname.lastname@example.org://www.aanmelder.nl/microbiome
Metabolomics & the Microbiome Meeting 2022Metabolomics & the Microbiome Meeting 20220.00EUROnlineOnly2019-01-01T00:00:00Z
DSMDSMAlexander Fleminglaan 1 2613 AX Delft Delft Netherlands